TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells
Related Experiment Video
Updated: Jun 5, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Dianne M Heijink1, Mathilde Jalving, Dorenda Oosterhuis
1Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, The Netherlands.
Abstract:
TNF-related apoptosis-inducing ligand (TRAIL) receptor agonistic agents and non-steroidal anti-inflammatory drugs (NSAIDs) are interesting agents for the chemoprevention and treatment of colorectal cancer. We investigated whether NSAIDs sensitize colon cancer and adenoma cell lines and ex vivo cultured human adenomas to recombinant human (rh)TRAIL. Involvement of the crucial Wnt signalling pathway in the sensitization of colon cancer cells was examined. Five colon cancer and two adenoma cell lines, human ex vivo adenomas and normal colonic epithelium were treated with aspirin or sulindac combined with rhTRAIL. Apoptosis levels, expression of intracellular proteins and TRAIL receptor membrane expression were assessed. Ls174T cells stably transfected with an inducible dominant negative TCF-4 (dnTCF-4) construct served to analyse the role of Wnt pathway activation. Both rhTRAIL-sensitive and -resistant colon cancer cell lines were strongly sensitized to rhTRAIL by aspirin (maximum enhancement ratio, 7.1). Remarkably, in adenoma cell lines sulindac enhanced rhTRAIL-induced apoptosis most effectively (maximum enhancement ratio, 2.5). Although membrane TRAIL receptor expression was not affected by NSAIDs, caspase-8 activation was enhanced by combinational treatment. Several proteins from different biological pathways were affected by NSAIDs, indicating complex mechanisms of sensitization. Elimination of TCF-4 completely blocked the sensitizing effect in colon cancer cells. In ex vivo adenomas the combination of sulindac and rhTRAIL increased apoptosis from 18.4% (sulindac) and 17.8% (rhTRAIL) to 28.0% (p = 0.003 and p = 0.005, respectively). It was concluded that NSAID-induced sensitization to rhTRAIL requires TCF-4 activity. Thus, the combination of TRAIL-receptor agonistic agents and NSAIDs is a potentially attractive treatment option for (pre)malignant tumours with constitutively active Wnt signalling, such as colorectal tumours.
Insights
Non-steroidal anti-inflammatory drugs (NSAIDs) enhance TRAIL-receptor agonistic agents
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Colorectal cancer chemoprevention and treatment can involve TNF-related apoptosis-inducing ligand (TRAIL) receptor agonists and non-steroidal anti-inflammatory drugs (NSAIDs).
- Investigating the synergistic effects of NSAIDs and TRAIL agonists in colorectal cancer is crucial for developing novel therapeutic strategies.
- The Wnt signalling pathway plays a significant role in colon cancer development and may influence treatment response.
Purpose of the Study:
- To determine if NSAIDs sensitize colon cancer and adenoma cell lines, as well as ex vivo human adenomas, to recombinant human (rh)TRAIL.
- To examine the involvement of the Wnt signalling pathway in NSAID-mediated sensitization to rhTRAIL.
- To assess the potential of combining TRAIL agonists and NSAIDs as a treatment for colorectal (pre)malignant tumours.
Main Methods:
- Treatment of colon cancer cell lines, adenoma cell lines, ex vivo human adenomas, and normal colonic epithelium with aspirin or sulindac in combination with rhTRAIL.
- Assessment of apoptosis levels, intracellular protein expression, and TRAIL receptor membrane expression.
- Utilisation of colon cancer cells with a dominant-negative TCF-4 construct to analyse the role of Wnt pathway activation.
Main Results:
- NSAIDs, particularly aspirin, significantly sensitized both rhTRAIL-sensitive and -resistant colon cancer cell lines to rhTRAIL (maximum enhancement ratio, 7.1).
- Sulindac demonstrated the most effective sensitization of adenoma cell lines to rhTRAIL (maximum enhancement ratio, 2.5).
- Combinational treatment enhanced caspase-8 activation, and NSAID-induced sensitization was dependent on TCF-4 activity, indicating Wnt pathway involvement.
Conclusions:
- NSAID-induced sensitization to rhTRAIL in colon cancer cells is dependent on TCF-4 activity, highlighting the importance of the Wnt signalling pathway.
- The combination of TRAIL-receptor agonistic agents and NSAIDs presents a promising therapeutic approach for colorectal tumours with active Wnt signalling.
- This combination therapy warrants further investigation for the treatment of (pre)malignant colorectal conditions.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
The Extrinsic Apoptotic Pathway